SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV
NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Verve Therapeutics, Inc. (“Verve” or the “Company”) (NASDAQ: VERV). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw. …